The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center

Abstract

Background and Objectives: An increasing incidence of non-melanoma skin cancer (NMSC) is noted, as well as an increasing cost of the treatment, with NMSC becoming a public health problem. We aimed to investigate the prevalence and treatment costs of surgically treated NMSC from the Oral and Maxillofacial Surgery Department of Cluj-Napoca County Hospital. Materials and Methods: We retrospectively analyzed the clinical data and the charge data of hospitalization from the informatic system of Cluj-Napoca County Hospital. All patients benefited from standard surgical excision with the reconstruction of the post-excisional defect. A statistical analysis of the costs related to the patients’ features, period and conditions of hospitalization, materials, medication, and paraclinical investigations was performed. Results: Between 2015 and 2019, 133 patients with NMSC were addressed to our department, with basal cell carcinoma (BCC) being four-fold higher than squamous cell carcinoma (SCC). Most NMSC cases were diagnosed in stage I or II, and they benefited from local reconstruction. The treatment costs progressively increased in the last five years, reaching a total cost of EUR ~13.000 in 2019. The treatment cost per episode was higher for SCC compared to BCC, while the total cost of treatment in 5 years was higher for BCC. Low income, immunosuppression, comorbidities, flap reconstruction option, long-lasting surgery, and prolonged hospitalization were associated with an increased cost of the treatment. Conclusion: The prevalence and treatment cost of surgically treated NMSC of the head and neck region increased in the last five years, with high-cost drivers being related to patients and treatment options.

Mixed Eccrine Cutaneous Tumor with Folliculo–Sebaceous Differentiation: Case Report and Literature Review

“…Concluding the correct diagnosis is of utmost importance not only for patient prognosis, but it has also been observed that treatment costs differ according to the type of the neoplasm. [ 18 ]…”

“…Concluding the correct diagnosis is of utmost importance not only for patient prognosis, but it has also been observed that treatment costs differ according to the type of the neoplasm. [18] The literature reviews suggest that recurrences were seen only when treatment consisted of electrodesiccation or incomplete excision. Lesions did not recur once they had been removed in toto [7].…”

Role of Insulin Use and Social Determinants of Health on Non-melanoma Skin Cancer: Results From the Behavioral Risk Factor Surveillance System

“…Non-melanoma skin cancer (NMSC) is the most common human malignancy 1 that was marked over the past decades by a substantial worldwide increase in incidence and morbidity, as well as associated cost of treatment. 2 - 4 This type of skin cancer manifests in the form of a lump or discolored patch that develops slowly in the upper layers of the skin and presents mostly on sun-exposed skin. 5 According to the World Health Organization (WHO), approximately 2 to 3 million new cases of NMSC are diagnosed each year globally, 6 and in North America, this disease is characterized as being one of the most prevalent types of cancer 7 , 8 particularly among the aging population of White males.…”